A Phase 3 Multicenter Open-Label Study Evaluating the Safety and Efficacy of Intravenous Tigecycline to Treat Hospitalized Japanese Subjects With Community-Acquired Pneumonia

Trial Profile

A Phase 3 Multicenter Open-Label Study Evaluating the Safety and Efficacy of Intravenous Tigecycline to Treat Hospitalized Japanese Subjects With Community-Acquired Pneumonia

Completed
Phase of Trial: Phase III

Latest Information Update: 02 Jun 2011

At a glance

  • Drugs Tigecycline (Primary)
  • Indications Bacterial infections; Community-acquired pneumonia
  • Focus Therapeutic Use
  • Sponsors Wyeth
  • Most Recent Events

    • 29 May 2009 Actual patient number (9) added as reported by ClinicalTrials.gov.
    • 29 May 2009 Status changed from discontinued to completed as reported by ClinicalTrials.gov.
    • 25 Jun 2008 Status change from recruiting to terminated as reported by clinicaltrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top